A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.RB3}BSC836 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(3L)BSC836 predicted from the Release 5 genomic coordinates of the progenitor P{XP}d09186 and PBac{RB}CG33214e03593 transposable element insertion sites are 3L:21375599 ;21490872 and the cytological breakpoints predicted from these coordinates are 78C9;78D4.